Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapy.

Saved in:
Bibliographic Details
Title: Epcoritamab as bridging therapy to successful second allogeneic HSCT in relapsed DLBCL after UCBT and CAR T cell therapy.
Authors: Chikagawa Y; Department of Internal Medicine, Komatsu Municipal Hospital, 60, Mukaimotoori-Machi, Komatsu, Ishikawa, 923-8560, Japan. ychikagawa.n1@gmail.com.; Department of Hematology, Kanazawa Medical Center, 1-1, Shimoishibiki-Machi, Kanazawa, Ishikawa, 920-8650, Japan. ychikagawa.n1@gmail.com., Higashi D; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Sakai S; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Yoshino H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Nukii Y; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Mura H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Nakagawa S; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Yamada S; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Yoroidaka T; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Imi T; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Zaimoku Y; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Maruyama H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Hosokawa K; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Aoki G; Department of Internal Medicine, Komatsu Municipal Hospital, 60, Mukaimotoori-Machi, Komatsu, Ishikawa, 923-8560, Japan., Yoshida A; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Takamatsu H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Yamazaki H; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan., Miyamoto T; Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1, Takara-Machi, Kanazawa, Ishikawa, 920-8641, Japan.
Source: International journal of hematology [Int J Hematol] 2026 Jan; Vol. 123 (1), pp. 141-145. Date of Electronic Publication: 2025 Oct 27.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1865-3774
DOI:10.1007/s12185-025-04091-0